KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Assets Average (2018 - 2025)

Amneal Pharmaceuticals (AMRX) has 5 years of Assets Average data on record, last reported at $3.5 billion in Q4 2024.

  • For Q4 2024, Assets Average changed N/A year-over-year to $3.5 billion; the TTM value through Dec 2024 reached $3.5 billion, changed N/A, while the annual FY2024 figure was $3.5 billion, 4.1% down from the prior year.
  • Assets Average reached $3.5 billion in Q4 2024 per AMRX's latest filing, roughly flat from $3.5 billion in the prior quarter.
  • Across five years, Assets Average topped out at $4.0 billion in Q1 2020 and bottomed at $3.5 billion in Q4 2024.
  • Average Assets Average over 4 years is $3.8 billion, with a median of $3.9 billion recorded in 2021.
  • Peak YoY movement for Assets Average: dropped 7.79% in 2020, then fell 1.12% in 2021.
  • A 4-year view of Assets Average shows it stood at $4.0 billion in 2020, then fell by 1.77% to $4.0 billion in 2021, then decreased by 3.04% to $3.8 billion in 2022, then fell by 9.27% to $3.5 billion in 2024.
  • Per Business Quant database, its latest 3 readings for Assets Average were $3.5 billion in Q4 2024, $3.5 billion in Q3 2024, and $3.8 billion in Q4 2022.